These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28635114)

  • 1. Longitudinal changes in peripheral oxidative markers in patients with Alzheimer's disease, with or without cardiovascular disease.
    Hatanaka H; Hirose D; Hirao K; Shimizu S; Kanetaka H; Hanyu H
    Geriatr Gerontol Int; 2017 Jun; 17(6):1035-1037. PubMed ID: 28635114
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
    Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
    Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil and platelet to lymphocyte ratios in people with subjective, mild cognitive impairment and early Alzheimer's disease.
    Kalelioglu T; Yuruyen M; Gultekin G; Yavuzer H; Özturk Y; Kurt M; Topcu Y; Doventas A; Emul M
    Psychogeriatrics; 2017 Nov; 17(6):506-508. PubMed ID: 28386987
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum zinc is an effect of ageing and not Alzheimer's disease.
    Rembach A; Hare DJ; Doecke JD; Burnham SC; Volitakis I; Fowler CJ; Cherny RA; McLean C; Grimm R; Martins R; Ames D; Masters CL; Bush AI; Roberts BR
    Metallomics; 2014 Jul; 6(7):1216-9. PubMed ID: 24676028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood test may predict progression to Alzheimer's disease, say researchers.
    Chinthapalli K
    BMJ; 2014 Jul; 349():g4506. PubMed ID: 25005148
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated plasma homocysteine level is not primarily related to Alzheimer's disease.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2012; 34(2):121-7. PubMed ID: 23006895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
    Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Yu Z
    Mol Med Rep; 2016 Oct; 14(4):3184-98. PubMed ID: 27511317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
    Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR
    Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.
    Furney SJ; Kronenberg D; Simmons A; Güntert A; Dobson RJ; Proitsi P; Wahlund LO; Kloszewska I; Mecocci P; Soininen H; Tsolaki M; Vellas B; Spenger C; Lovestone S
    J Alzheimers Dis; 2011; 26 Suppl 3():395-405. PubMed ID: 21971479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China.
    Yuan L; Liu J; Ma W; Dong L; Wang W; Che R; Xiao R
    Nutrition; 2016 Feb; 32(2):193-8. PubMed ID: 26690564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease.
    Di Domenico F; Barone E; Mancuso C; Perluigi M; Cocciolo A; Mecocci P; Butterfield DA; Coccia R
    J Alzheimers Dis; 2012; 32(2):277-89. PubMed ID: 22776971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients.
    Rubio-Perez JM; Albaladejo MD; Zafrilla P; Vidal-Guevara ML; Morillas-Ruiz JM
    Eur J Nutr; 2016 Sep; 55(6):2105-16. PubMed ID: 26298312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging new biomarkers of Alzheimer's disease.
    Kapoor S
    Int J Geriatr Psychiatry; 2013 Aug; 28(8):880. PubMed ID: 23832547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.